“Lyme disease caused by the spirochete Borrelia burgdorferi and transmitted by vector Ixodes scapular, is the most commonly reported vector-borne illness in the United States. Lyme disease incidence is increasing throughout the world.
Lyme disease diagnostic devices market has been segmented by diagnostic tests, diagnostic technologies and end users. Each of these segmentations has been further classified into sub segments to give an in-depth and comprehensive analysis of the Lyme disease diagnostic devices market.
Further the report provides geographic analysis of the Lyme disease and lists major companies involved in manufacturing of innovative diagnostic devices devices for the treatment of Lyme disease.”
“1. Lyme Disease diagnostic devices- Market Overview
2. Executive Summary
3. Lyme Disease diagnostic devices – Market Landscape
3.1 Market Share Analysis
3.2 Comparative Analysis
3.2.1 Product Benchmarking
3.2.2 Patent Analysis
3.2.3 Top 5 Financials Analysis
4. Lyme Disease diagnostic devices – Market Forces
4.1. Market Drivers
4.2. Market Constraints
4.3. Market Challenges
4.4 Attractiveness of the Industry
4.4.1 Power of Suppliers
4.4.2 Power of Customers
4.4.3 Threat of New entrants
4.4.4 Threat of Substitution
4.4.5 Degree of Competition
5. Lyme Disease diagnostic devices – Strategic Analysis
5.1. Value Chain Analysis
5.2. Opportunities Analysis
5.3. Product lifecycle
5.4. Pricing Analysis
6. Lyme Disease diagnostic devices market – By Diagnostic Tests
6.1 Serological tests
6.1.1 ELISA (Enzyme-linked Immunosorbent Assay)
6.1.2 ELFA (Enzyme-linked Fluorescent Immunoassay)
6.1.3 Western Blot
6.2 Lymphocytic transformation test
6.3 Immunofluorescence staining
6.4 PCR Analysis
6.5 Urine antigen tests
6.6 Dark field microscopy
7. Lyme Disease diagnostic devices market- By Diagnostic Technologies
7.1 Molecular diagnostics
7.2 Brain MRI
7.3 Spinal tap
7.4 Echocardiogram
7.5 Electrocardiogram
7.6 Monoclonal antibodies
7.7 Flow cytometry
7.8 Gel micro droplets
8. Lyme Disease diagnostic devices market – By End Users
8.1 Hospitals / Clinics
8.2 Pharmaceutical Industries
8.3 Pathology labs
8.4 Research Institutes
9. Lyme Disease diagnostic devices market- By Geographic Analysis
9.1 Americas
9.1.1. USA
9.1.2. Canada
9.2 Europe
9.2.1 United kingdom
9.2.3 Slovenia
9.2.3 Austria
9.2.4 Italy
9.2.5 Portugal
9.3 Africa
9.3.1 Morocco
9.3.2 Algeria
9.3.3 Egypt
9.3.4 Tunisia
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Thailand
9.4.5 Russia
9.4.6 Others
9.5 ROW
10. Company Profiles
10.1 Abbott Laboratories
10.2 Canon U.S. Life Sciences
10.3 T2 Biosystems
10.4 Bio-Rad Laboratories
10.5 Alere Inc (ALR)
10.6 Roche Diagnostics International Ltd.
10.7 Graphene Frontiers
10.8 Covance Inc.
10.9 Boulder Diagnostics
10.10 Immunetics Inc.
10.11 GlaxoSmithKline Pharmaceuticals Ltd.
10.12 Affymetrix Inc.
10.13 Siemens AG
10.14 Baxter International Inc.
10.15 Fresenius Medical Care AG & Co.
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
“”*Financials would be provided on a best efforts basis for private companies””
11. Appendix
11.1. Abbreviations
11.2. Sources
11.3. Research Methodology
11.4. Bibliography
11.5. Compilation of Expert Insights
11.6. Disclaimer”
“10.1 Abbott Laboratories
10.2 Canon U.S. Life Sciences
10.3 T2 Biosystems
10.4 Bio-Rad Laboratories
10.5 Alere Inc (ALR)
10.6 Roche Diagnostics International Ltd.
10.7 Graphene Frontiers
10.8 Covance Inc.
10.9 Boulder Diagnostics
10.10 Immunetics Inc.
10.11 GlaxoSmithKline Pharmaceuticals Ltd.
10.12 Affymetrix Inc.
10.13 Siemens AG
10.14 Baxter International Inc.
10.15 Fresenius Medical Care AG & Co.”
